Q-TWiST Analysis to Assess Benefit-Risk of Sacituzumab Govitecan in Previously Treated Patients With Metastatic Triple-Negative Breast Cancer. uri icon

authors

  • Bardia, Aditya
  • O'Shaughnessy, Joyce A
  • Dieras, Véronique
  • Piccart-Gebhart, Martine J
  • Dasgupta, Anandaroop
  • Kaushik, Ankita
  • Lai, Catherine
  • Shi, Ling
  • Brufsky, Adam
  • Rugo, Hope S
  • Mina S. Sedrak, MD, MS
  • Loibl, Sibylle
  • Tolaney, Sara M
  • Punie, Kevin
  • Hurvitz, Sara A
  • Kalinsky, Kevin M
  • Cortés, Javier